keyword
MENU ▼
Read by QxMD icon Read
search

Fibrometer

keyword
https://www.readbyqxmd.com/read/27897323/prognostic-durability-of-liver-fibrosis-tests-and-improvement-in-predictive-performance-for-mortality-by-combining-tests
#1
Sandrine Bertrais, Jérôme Boursier, Alexandra Ducancelle, Frédéric Oberti, Isabelle Fouchard-Hubert, Valérie Moal, Paul Calès
BACKGROUND AND AIM: There is currently no recommended time interval between non-invasive fibrosis measurements for monitoring chronic liver diseases. We determined how long a single liver fibrosis evaluation may accurately predict mortality, and assessed whether combining tests improves prognostic performance. METHODS: We included 1559 patients with chronic liver disease and available baseline liver stiffness measurement (LSM) by Fibroscan, APRI, FIB-4, Hepascore, and FibroMeter(V2G) ...
November 29, 2016: Journal of Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/27380461/biomarkers-of-hepatic-fibrosis-in-chronic-hepatitis-c-a-comparison-of-10-biomarkers-using-2-different-assays-for-hyaluronic-acid
#2
Sudeep Tanwar, Paul M Trembling, Brian J Hogan, Julie Parkes, Scott Harris, Paul Grant, Eleni Nastouli, Mathias Ocker, Klaus Wehr, Christoph Herold, Daniel Neureiter, Detlef Schuppan, William M Rosenberg
BACKGROUND: Advancing fibrosis is regarded as the most important factor when stratifying patients with chronic hepatitis C for retreatment. GOALS: (1) To compare the performance of 10 biomarkers of fibrosis, including patented tests, among patients with chronic hepatitis C and treatment failure; and (2) to assess the impact on biomarker performance of using 2 different assays of hyaluronic acid (HA). STUDY: For 80 patients, liver histology (Metavir) was compared with biomarker scores using sera obtained within 6 months of liver biopsy (indirect biomarkers: AST:ALT ratio, APRI, Forns index, FIB-4, Fibrometer V3G; direct biomarkers: ELF, Fibrospect II, Hyaluronic acid-HA, Fibrometer V2G, Hepascore)...
July 1, 2016: Journal of Clinical Gastroenterology
https://www.readbyqxmd.com/read/27196548/diagnostic-accuracy-of-apri-fib-4-and-forns-for-the-detection-of-liver-cirrhosis-in-hiv-hcv-coinfected-patients
#3
Marco Merli, Antonella Castagna, Stefania Salpietro, Nicola Gianotti, Emanuela Messina, Andrea Poli, Giulia Morsica, Sabrina Bagaglio, Massimo Cernuschi, Alba Bigoloni, Caterina Uberti-Foppa, Adriano Lazzarin, Hamid Hasson
Non-invasive assessment of liver fibrosis represents an appealing method to monitor liver disease in HCV-infected patients. Currently, transient elastography (TE) is the most accurate non-invasive tool to measure liver stiffness (LS), with the diagnostic accuracy increasing together with the stage of fibrosis (Friedrich Rust et al., 2008; Degos et al., 2010). Stiffness measurement is widely used in the assessment of fibrosis in patients with chronic hepatitis C given its good reproducibility (Fraquelli et al...
April 2016: New Microbiologica
https://www.readbyqxmd.com/read/27155555/association-between-severity-of-obstructive-sleep-apnea-and-blood-markers-of-liver-injury
#4
Wojciech Trzepizur, Jérôme Boursier, Yasmina Mansour, Marc Le Vaillant, Sylvaine Chollet, Thierry Pigeanne, Acya Bizieux-Thaminy, Marie-Pierre Humeau, Claire Alizon, François Goupil, Nicole Meslier, Pascaline Priou, Paul Calès, Frédéric Gagnadoux
Obstructive sleep apnea (OSA) may contribute to the development of nonalcoholic fatty liver disease. We performed a multisite cross-sectional study to evaluate the association between the severity of OSA and blood markers of liver steatosis (using the hepatic steatosis index), cytolysis (based on alanine aminotransferase activity), and significant liver fibrosis (based on the FibroMeter [Echosens] nonalcoholic fatty liver disease score) in 1285 patients with suspected OSA in France. After adjusting for confounders including central obesity, the risk of liver steatosis increased with the severity of OSA (P for trend < ...
November 2016: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/27151181/diagnostic-accuracy-and-prognostic-significance-of-blood-fibrosis-tests-and-liver-stiffness-measurement-by-fibroscan-in-non-alcoholic-fatty-liver-disease
#5
Jérôme Boursier, Julien Vergniol, Anne Guillet, Jean-Baptiste Hiriart, Adrien Lannes, Brigitte Le Bail, Sophie Michalak, Faiza Chermak, Sandrine Bertrais, Juliette Foucher, Frédéric Oberti, Maude Charbonnier, Isabelle Fouchard-Hubert, Marie-Christine Rousselet, Paul Calès, Victor de Lédinghen
BACKGROUND & AIMS: NAFLD is highly prevalent but only a small subset of patients develop advanced liver fibrosis with impaired liver-related prognosis. We aimed to compare blood fibrosis tests and liver stiffness measurement (LSM) by FibroScan for the diagnosis of liver fibrosis and the evaluation of prognosis in NAFLD. METHODS: Diagnostic accuracy was evaluated in a cross-sectional study including 452 NAFLD patients with liver biopsy (NASH-CRN fibrosis stage), LSM, and eight blood fibrosis tests (BARD, NAFLD fibrosis score, FibroMeter(NAFLD), aspartate aminotransferase to platelet ratio index (APRI), FIB4, FibroTest, Hepascore, FibroMeter(V2G))...
September 2016: Journal of Hepatology
https://www.readbyqxmd.com/read/26713759/performance-of-non-invasive-models-of-fibrosis-in-predicting-mild-to-moderate-fibrosis-in-patients-with-non-alcoholic-fatty-liver-disease
#6
Mohammad S Siddiqui, Kavish R Patidar, Sherry Boyett, Velimir A Luketic, Puneet Puri, Arun J Sanyal
BACKGROUND & AIMS: In non-alcoholic fatty liver disease, presence of fibrosis is predictive of long-term liver-related complications. Currently, there are no reliable and non-invasive means of quantifying fibrosis in those with non-alcoholic fatty liver disease. Therefore, we aimed to evaluate the performance of a panel of non-invasive models in predicting fibrosis in non-alcoholic fatty liver disease. METHODS: The accuracy of FibroMeter non-alcoholic fatty liver disease, fibrosis 4 and four other non-invasive models in predicting fibrosis in those with biopsy proven non-alcoholic fatty liver disease was compared...
April 2016: Liver International: Official Journal of the International Association for the Study of the Liver
https://www.readbyqxmd.com/read/26469113/current-possibilities-to-assess-the-degree-of-liver-fibrosis-in-patients-with-haemophilia-infected-with-hcv-review
#7
REVIEW
Marta Kucharska, Marcin Inglot, Małgorzata Kuliszkiewicz-Janus, Monika Pazgan-Simon, Brygida Knysz
Haemophilia is an entity, wherein the HCV infection rate is greater than in the general population and ranges between 70-90%. The majority of HCV infections were acquired by hemophiliacs in the 1980s, by the use of infected cryoprecipitate or fresh frozen plasma preparations. It is therefore highly likely that many of them, more than twenty years after the infection, have developed advanced liver disease. Until recently, in order to assess its severity, it was necessary to perform a liver biopsy. Currently, we observe rapid developments of non-invasive methods that are particularly useful in patients with bleeding disorders...
July 2015: Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University
https://www.readbyqxmd.com/read/26270952/should-hfe-p-c282y-homozygotes-with-moderately-elevated-serum-ferritin-be-treated-a-randomised-controlled-trial-comparing-iron-reduction-with-sham-treatment-mi-iron
#8
RANDOMIZED CONTROLLED TRIAL
Sim Yee Ong, Lara Dolling, Jeannette L Dixon, Amanda J Nicoll, Lyle C Gurrin, Michelle Wolthuizen, Erica M Wood, Greg J Anderson, Grant A Ramm, Katrina J Allen, John K Olynyk, Darrell Crawford, Jennifer Kava, Louise E Ramm, Paul Gow, Simon Durrant, Lawrie W Powell, Martin B Delatycki
INTRODUCTION: HFE p.C282Y homozygosity is the most common cause of hereditary haemochromatosis. There is currently insufficient evidence to assess whether non-specific symptoms or hepatic injury in homozygotes with moderately elevated iron defined as a serum ferritin (SF) of 300-1000 µg/L are related to iron overload. As such the evidence for intervention in this group is lacking. We present here methods for a study that aims to evaluate whether non-specific symptoms and hepatic fibrosis markers improve with short-term normalisation of SF in p...
August 12, 2015: BMJ Open
https://www.readbyqxmd.com/read/26132343/assessing-liver-disease-in-hiv-hcv-coinfected-patients
#9
REVIEW
Emmanuel A Tsochatzis, Laurent Castera
PURPOSE OF REVIEW: It is estimated that up to 10% of patients with HIV have chronic hepatitis C (HCV)-HIV coinfection in the Western world. Assessment of liver disease is essential in such patients in order to diagnose cirrhosis at an early stage, prioritize for anti-HCV treatment but also assess fibrosis regression after sustained viral response (SVR). In this review, we present a critical appraisal of liver disease assessment in patients with HIV-HCV co-infection. RECENT FINDINGS: Liver biopsy has largely been replaced by noninvasive fibrosis assessment in most coinfected patients, although it is still of value if there are concerns of additional diagnoses...
September 2015: Current Opinion in HIV and AIDS
https://www.readbyqxmd.com/read/26049712/diagnostic-usefulness-of-fibrometer-vcte-for-hepatic-fibrosis-in-patients-with-nonalcoholic-fatty-liver-disease
#10
Elif Dincses, Yusuf Yilmaz
BACKGROUND: Liver fibrosis is an important prognostic determinant in patients with nonalcoholic fatty liver disease (NAFLD). The FibroMeter VCTE is a diagnostic tool comprising both biochemical markers and transient elastography (TE) originally developed for the diagnosis of fibrosis in patients with chronic viral hepatitis. In this pilot study, we investigated the diagnostic performance of the FibroMeter VCTE tool for determining fibrosis in patients with biopsy-proven NAFLD. Its diagnostic accuracy was also compared with those of the NAFLD fibrosis score (NFSA) and TE alone...
October 2015: European Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/25755423/non-invasive-diagnosis-of-fibrosis-in-non-alcoholic-fatty-liver-disease
#11
Anil Arora, Praveen Sharma
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed as well as in developing countries. Its prevalence continues to rise currently affecting approximately 20-30% of adults and 10% of children in the United States. Non-alcoholic fatty liver disease represents a wide spectrum of conditions ranging from fatty liver, which in general follows a benign non-progressive clinical course, to non-alcoholic steatohepatitis (NASH), a more serious form of NAFLD that may progress to cirrhosis and end-stage liver disease...
June 2012: Journal of Clinical and Experimental Hepatology
https://www.readbyqxmd.com/read/25486027/comparison-of-noninvasive-scores-for-the-detection-of-advanced-fibrosis-in-patients-with-nonalcoholic-fatty-liver-disease
#12
COMPARATIVE STUDY
Cemal F Subasi, Umut E Aykut, Yusuf Yilmaz
BACKGROUND: The presence of advanced liver fibrosis portends a poor prognosis in nonalcoholic fatty liver disease (NAFLD). We aimed to compare the diagnostic performance of five noninvasive scores [aspartate aminotransferase/platelet ratio (APRI), BARD, FIB-4, NAFLD fibrosis score (NFSA), and FibroMeter] for the assessment of advanced stages of fibrosis (F ≥ 3) in patients with biopsy-proven NAFLD. METHODS: APRI, BARD, FIB-4, NFSA, and FibroMeter scores were determined in 142 patients with NAFLD...
February 2015: European Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/25259621/a-comparison-of-fibrometer%C3%A2-nafld-score-nafld-fibrosis-score-and-transient-elastography-as-noninvasive-diagnostic-tools-for-hepatic-fibrosis-in-patients-with-biopsy-proven-non-alcoholic-fatty-liver-disease
#13
COMPARATIVE STUDY
Umut Emre Aykut, Umit Akyuz, Atakan Yesil, Fatih Eren, Fatma Gerin, Rabia Ergelen, Cigdem Ataizi Celikel, Yusuf Yilmaz
BACKGROUND: Noninvasive markers that purport to distinguish patients with non-alcoholic fatty liver disease (NAFLD) with fibrosis from those without must be evaluated rigorously for their classification accuracy. Herein, we seek to compare the diagnostic performances of three different noninvasive methods (FibroMeter™ NAFLD score, NAFLD Fibrosis score (NFSA), and Transient Elastrography [TE]) for the detection of liver fibrosis in NAFLD patients. METHODS: A total of 88 patients with biopsy-proven NAFLD were included...
November 2014: Scandinavian Journal of Gastroenterology
https://www.readbyqxmd.com/read/24889599/combination-of-blood-tests-for-significant-fibrosis-and-cirrhosis-improves-the-assessment-of-liver-prognosis-in-chronic-hepatitis-c
#14
J Boursier, C Brochard, S Bertrais, S Michalak, Y Gallois, I Fouchard-Hubert, F Oberti, M-C Rousselet, P Calès
BACKGROUND: Recent longitudinal studies have emphasised the prognostic value of noninvasive tests of liver fibrosis and cross-sectional studies have shown their combination significantly improves diagnostic accuracy. AIM: To compare the prognostic accuracy of six blood fibrosis tests and liver biopsy, and evaluate if test combination improves the liver-prognosis assessment in chronic hepatitis C (CHC). METHODS: A total of 373 patients with compensated CHC, liver biopsy (Metavir F) and blood tests targeting fibrosis (APRI, FIB4, Fibrotest, Hepascore, FibroMeter) or cirrhosis (CirrhoMeter) were included...
July 2014: Alimentary Pharmacology & Therapeutics
https://www.readbyqxmd.com/read/24631902/prospective-evaluation-of-fibrotest%C3%A2-fibrometer%C3%A2-and-hepascore%C3%A2-for-staging-liver-fibrosis-in-chronic-hepatitis-b-comparison-with-hepatitis-c
#15
COMPARATIVE STUDY
Vincent Leroy, Nathalie Sturm, Patrice Faure, Candice Trocme, Alice Marlu, Marie-Noëlle Hilleret, Françoise Morel, Jean-Pierre Zarski
BACKGROUND & AIMS: Fibrosis blood tests have been validated in chronic hepatitis C. Their diagnostic accuracy is less documented in hepatitis B. The aim of this study was to describe the diagnostic performance of FibroTest®, FibroMeter®, and HepaScore® for liver fibrosis in hepatitis B compared to hepatitis C. METHODS: 510 patients mono-infected with hepatitis B or C and matched on fibrosis stage were included. Blood tests were performed the day of the liver biopsy...
July 2014: Journal of Hepatology
https://www.readbyqxmd.com/read/24102852/improved-fibrosis-staging-by-elastometry-and-blood-test-in-chronic-hepatitis-c
#16
COMPARATIVE STUDY
Paul Calès, Jérôme Boursier, Alexandra Ducancelle, Frédéric Oberti, Isabelle Hubert, Gilles Hunault, Victor de Lédinghen, Jean-Pierre Zarski, Dominique Salmon, Françoise Lunel
AIMS: Our main objective was to improve non-invasive fibrosis staging accuracy by resolving the limits of previous methods via new test combinations. Our secondary objectives were to improve staging precision, by developing a detailed fibrosis classification, and reliability (personalized accuracy) determination. METHODS: All patients (729) included in the derivation population had chronic hepatitis C, liver biopsy, 6 blood tests and Fibroscan. Validation populations included 1584 patients...
July 2014: Liver International: Official Journal of the International Association for the Study of the Liver
https://www.readbyqxmd.com/read/23796871/impact-of-hepatitis-b-and-delta-virus-co-infection-on-liver-disease-in-mauritania-a-cross-sectional-study
#17
Françoise Lunel-Fabiani, Wael Mansour, Abdellahi Ould Amar, Mohamed Aye, Frédéric Le Gal, F-Zahra Fall Malick, Lô Baïdy, Ségolène Brichler, Pascal Veillon, Alexandra Ducancelle, Emmanuel Gordien, Michel Rosenheim
OBJECTIVES: Mauritania is a highly endemic region for hepatitis B (HBV) and delta (HDV) viruses. No data are available on HDV's impact on the severity of liver disease in consecutive HBV-infected patients in Africa. This study evaluated the degree of liver fibrosis in a cohort of chronic HBV carriers. METHODS: Three-hundred consecutive HBV-infected Mauritanian patients were checked for HDV infection via the detection of anti-HDV antibodies (Ab) and viral RNA. HBV- vs...
November 2013: Journal of Infection
https://www.readbyqxmd.com/read/23555619/contribution-of-the-elfg-test-in-algorithms-of-non-invasive-markers-towards-the-diagnosis-of-significant-fibrosis-in-chronic-hepatitis-c
#18
Jean-Pierre Zarski, Nathalie Sturm, Jérôme Guechot, Elie-Serge Zafrani, Michel Vaubourdolle, Sophie Thoret, Jennifer Margier, Sandra David-Tchouda, Jean-Luc Bosson
BACKGROUND AND AIMS: We aimed to determine the best algorithms for the diagnosis of significant fibrosis in chronic hepatitis C (CHC) patients using all available parameters and tests. PATIENTS AND METHODS: We used the database from our study of 507 patients with histologically proven CHC in which fibrosis was evaluated by liver biopsy (Metavir) and tests: Fibrometer®, Fibrotest®, Hepascore®, Apri, ELFG, MP3, Forn's, hyaluronic acid, tissue inhibitor of metalloproteinase-1 (TIMP1), MMP1, collagen IV and when possible Fibroscan™...
2013: PloS One
https://www.readbyqxmd.com/read/23278163/review-article-the-diagnosis-of-non-alcoholic-fatty-liver-disease-availability-and-accuracy-of-non-invasive-methods
#19
REVIEW
D Festi, R Schiumerini, L Marzi, A R Di Biase, D Mandolesi, L Montrone, E Scaioli, G Bonato, G Marchesini-Reggiani, A Colecchia
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of clinical conditions, actually representing an emerging disease of great clinical interest. Currently, its diagnosis requires liver biopsy, an invasive procedure not free from potential complications. However, several non-invasive diagnostic strategies have been proposed as potential diagnostic alternatives, each with different sensitivities and accuracies. AIM: To review non-invasive diagnostic parameters and tools for NAFLD diagnosis and to formulate a diagnostic and prognostic algorithm for a better classification of patients...
February 2013: Alimentary Pharmacology & Therapeutics
https://www.readbyqxmd.com/read/23216352/cutoff-values-for-alcoholic-liver-fibrosis-using-magnetic-resonance-elastography-technique
#20
Sabine F Bensamoun, Gwladys E Leclerc, Laëtitia Debernard, Xiaobin Cheng, Ludovic Robert, Fabrice Charleux, Colette Rhein, Jean-Paul Latrive
BACKGROUND: Due to the lack of cutoff values validated for specific liver diseases, the purpose of this study was to set up specific magnetic resonance elastography (MRE) cutoff values for asymptomatic liver fibrosis in alcoholic patients. METHODS: Ninety patients underwent 3 clinical exams. The liver stiffness was measured locally with the Fibroscan, and globally through cartographies of shear modulus generated with MRE. The Fibroscan method was chosen as the gold standard to classify the fibrosis...
May 2013: Alcoholism, Clinical and Experimental Research
keyword
keyword
69614
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"